Researchers from Tufts University School of Dental Medicine have developed lab-grown skin that replicates the complexity of ...

New 3D tissue model offers a breakthrough tool for understanding and treating scleroderma and other fibrotic diseases.

Using skin and blood samples from scleroderma patients, the team grew lab-based skin: pinkish, pancake-like, little disks of ...

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic ...

A research team led by Prof. LI Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has developed a new model that can accurately predict lung motion caused by ...

Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple models of lung injury. The research indicates that macrophages previously ...

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood cells that defend the body by killing microbes, removing dead cells ...

Endeavor’s lead candidate, taladegib (ENV-101), is an inhibitor of the Hedgehog signaling pathway in development for fibrotic lung diseases, including idiopathic pulmonary fibrosis (IPF).